Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma.
Gordon SW, McGuire WP 3rd, Shafer DA, Sterling RK, Lee HM, Matherly SC, Roberts JD, Bose P, Tombes MB, Shrader EE, Ryan AA, Kmieciak M, Nguyen T, Deng X, Bandyopadhyay D, Dent P, Poklepovic AS.
Gordon SW, et al. Among authors: ryan aa.
Am J Clin Oncol. 2019 Aug;42(8):649-654. doi: 10.1097/COC.0000000000000567.
Am J Clin Oncol. 2019.
PMID: 31305287
Clinical Trial.